scispace - formally typeset
S

Shinae Kizaka-Kondoh

Researcher at Tokyo Institute of Technology

Publications -  110
Citations -  4936

Shinae Kizaka-Kondoh is an academic researcher from Tokyo Institute of Technology. The author has contributed to research in topics: Tumor hypoxia & Gene. The author has an hindex of 36, co-authored 102 publications receiving 4399 citations. Previous affiliations of Shinae Kizaka-Kondoh include Kyoto University.

Papers
More filters
Journal ArticleDOI

Induction of hypoxia-inducible factor 1 activity by muscarinic acetylcholine receptor signaling.

TL;DR: It is concluded that muscarinic acetylcholine signals activate HIF-1 by both stabilization and synthesis of Hif-1α and by inducing the transcriptional activity of HIF -1α.
Journal ArticleDOI

The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts.

TL;DR: A novel HIF-1-dependent reporter gene is constructed, 5HREp-ODD-luc, in which 5 copies of the hypoxia-response element (5HRE) enhance expression of the oxygen-dependent degradation (ODD) domain and luciferase (luc) fusion under Hypoxia, which will surely accelerate analysis of the intratumoral Hif-1 activity during tumor progression and cancer treatments.
Journal ArticleDOI

Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow.

TL;DR: BMMNC treatment provides marked protection against ischemic WM damage, enhancing CBF in the early phase and in subsequent angiogenesis, both of which involve nitric oxide synthase activation.
Journal ArticleDOI

Biomedical applications of imidazolium cation-modified iron oxide nanoparticles

TL;DR: In this paper, the synthesis of N-methylimidazolium chloride-modified iron oxide nanoparticles (MImCl-NPs) by condensation of an imidazolate cation-containing silane coupling agent was reported.
Journal ArticleDOI

Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation.

TL;DR: It is reported that CPP/PTDs facilitate the extravasation of fused proteins by binding to neuropilin-1 (NRP1), a vascular endothelial growth factor co-receptor expressed on the surface of endothelial and some tumor cells.